CeriBell, Inc.
NASDAQ:CBLLMedical - Devices
+$0.25 today
- Market cap
- $995.34M
- Beta
- 0.84
- P/E (TTM)
- -10.9
- EPS (TTM)
- -$1.60
Volume 0.41M
Average 0.29M
CBLL Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
CeriBell, Inc.NASDAQ: CBLL
Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026
Accumulated OCI turns positive
Q1 FY2026 Accumulated OCI was $18K, compared with -$6K a year earlier.
Context
- Accumulated OCI amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Accumulated OCI increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps rising in the next quarterly balance sheet after a +400.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- 159K USD
- Year-over-year change
- —
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 159K | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
Accumulated OCI vs competitors
How CBLL compares with its peers on the latest reported figures
- CBLL's Mar 2026 Accumulated OCI of $18K is the highest of the 7 companies compared; the peer median is -$32K.
- Its year-over-year change of +400.0% is the highest of 5, against a peer median of -50.0%.
- Accumulated OCI amounts to 0.0% of total assets for CBLL, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
CBLLCeriBell, Inc. | Mar 2026 | $18K | +400.0% | — | 0.0% |
| Sep 2026 | $0 | -100.0% | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | -$64K | -191.4% | — | 0.4% | |
| Mar 2026 | -$203K | +1.0% | — | 0.2% | |
| Mar 2026 | -$2.19M | +0.0% | — | 1.9% | |
| Peer median (excluding CBLL) | -$32K | -50.0% | — | 0.1% | |
Competitors are the stored peer set for CBLL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Cash & Equivalents | 68.24M | 34.5M | 194.37M | 40.48M |
| Short-term Investments | 0 | 0 | 0 | 118.79M |
| Net Receivables | 5.3M | 7.96M | 10.88M | 15.05M |
| Inventory | 4.08M | 5.87M | 6.94M | 7.29M |
| Other Current Assets | 2.19M | 3.65M | 5.09M | 5.12M |
| Total Current Assets | 79.8M | 51.96M | 217.27M | 186.72M |
| Property, Plant & Equipment (Net) | 3.87M | 3.74M | 4.45M | 4.33M |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 805K |
| Long-term Investments | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 2.79M | 3.22M | 3.7M | 3.95M |
| Total Non-current Assets | 6.66M | 6.96M | 8.14M | 9.09M |
| Total Assets | 86.46M | 58.92M | 225.41M | 195.8M |
| Account Payables | 423K | 732K | 1.14M | 2.84M |
| Short-term Debt | 2.5M | 11.83M | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 |
| Deferred Revenue | 343K | 206K | 97K | 101K |
| Other Current Liabilities | 2.51M | 3.73M | 5M | 4.01M |
| Total Current Liabilities | 9.86M | 21.6M | 12.99M | 19.19M |
| Long-term Debt | 12.72M | 0 | 19.56M | 19.81M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 44K | 30K | 0 |
| Other Non-current Liabilities | 147.9M | 147.85M | 356K | 106K |
| Total Non-current Liabilities | 162.99M | 149.57M | 21.26M | 21.17M |
| Total Liabilities | 172.86M | 171.17M | 34.25M | 40.47M |
| Common Stock | 5K | 5K | 36K | 38K |
| Retained Earnings | (97.03M) | (126.49M) | (166.94M) | (220.36M) |
| Accumulated OCI | 0 | 0 | 0 | 159K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Total Equity | (86.4M) | (112.25M) | 191.17M | 155.34M |
| Total Debt | 18.22M | 14.2M | 21.96M | 22.28M |
| Net Debt | (50.02M) | (20.29M) | (172.41M) | (18.2M) |
CeriBell, Inc.
NASDAQ:CBLL
Intrinsic Alpha fair value
Locked
Current Price
$25.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.